233 related articles for article (PubMed ID: 31883830)
1. Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection.
Watanabe-Kusunoki K; Nakazawa D; Kusunoki Y; Kudo T; Hattanda F; Nishio S; Masuda S; Tomaru U; Kondo T; Atsumi T; Ishizu A
J Autoimmun; 2020 Mar; 108():102390. PubMed ID: 31883830
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis.
Ueda Y; Nakazawa D; Nishio S; Shiratori-Aso S; Kudo T; Miyoshi-Harashima A; Watanabe-Kusunoki K; Hattanda F; Iwasaki S; Tsuji T; Tomaru U; Aratani Y; Yamamoto M; Ishizu A; Atsumi T
Kidney Int; 2024 Jun; 105(6):1291-1305. PubMed ID: 38537677
[TBL] [Abstract][Full Text] [Related]
3. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.
Schreiber A; Rousselle A; Becker JU; von Mässenhausen A; Linkermann A; Kettritz R
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9618-E9625. PubMed ID: 29078325
[TBL] [Abstract][Full Text] [Related]
4. Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
Masuda S; Nonokawa M; Futamata E; Nishibata Y; Iwasaki S; Tsuji T; Hatanaka Y; Nakazawa D; Tanaka S; Tomaru U; Kawakami T; Atsumi T; Ishizu A
Am J Pathol; 2019 Apr; 189(4):839-846. PubMed ID: 30677396
[TBL] [Abstract][Full Text] [Related]
5. Thrombomodulin as a Physiological Modulator of Intravascular Injury.
Watanabe-Kusunoki K; Nakazawa D; Ishizu A; Atsumi T
Front Immunol; 2020; 11():575890. PubMed ID: 33042158
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of astaxanthin on ANCA-associated vasculitis.
Sun RL; Shang JC; Han RH; Xing GQ
Int Immunopharmacol; 2024 May; 132():111928. PubMed ID: 38537540
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Thrombomodulin Suppresses Histone-Induced Neutrophil Extracellular Trap Formation.
Shrestha B; Ito T; Kakuuchi M; Totoki T; Nagasato T; Yamamoto M; Maruyama I
Front Immunol; 2019; 10():2535. PubMed ID: 31736962
[TBL] [Abstract][Full Text] [Related]
8. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A
Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis.
Tang S; Zhang Y; Yin SW; Gao XJ; Shi WW; Wang Y; Huang X; Wang L; Zou LY; Zhao JH; Huang YJ; Shan LY; Gounni AS; Wu YZ; Zhang JB
Clin Exp Immunol; 2015 Jun; 180(3):408-18. PubMed ID: 25644394
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of ANCA-associated vasculitis: An update.
Jarrot PA; Kaplanski G
Autoimmun Rev; 2016 Jul; 15(7):704-13. PubMed ID: 26970490
[TBL] [Abstract][Full Text] [Related]
12. Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report.
Shida H; Hashimoto N; Kusunoki Y; Hattanda F; Ogawa Y; Hayashi T; Nakazawa D; Masuda S; Tomaru U; Ishizu A
BMC Nephrol; 2018 Jun; 19(1):145. PubMed ID: 29929470
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil extracellular traps can activate alternative complement pathways.
Wang H; Wang C; Zhao MH; Chen M
Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?
O'Sullivan KM; Holdsworth SR
Front Immunol; 2021; 12():635188. PubMed ID: 33790907
[TBL] [Abstract][Full Text] [Related]
15. The involvement of NETs in ANCA-associated vasculitis.
Shiratori-Aso S; Nakazawa D
Front Immunol; 2023; 14():1261151. PubMed ID: 37781373
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014.
Schönermarck U; Csernok E; Gross WL
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i46-52. PubMed ID: 25540095
[TBL] [Abstract][Full Text] [Related]
17. The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis.
Takeda S; Watanabe-Kusunoki K; Nakazawa D; Kusunoki Y; Nishio S; Atsumi T
Front Immunol; 2019; 10():1334. PubMed ID: 31249574
[No Abstract] [Full Text] [Related]
18. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical immunoglobulins reduce neutrophil extracellular trap formation and ameliorate the development of MPO-ANCA-associated vasculitis.
Uozumi R; Iguchi R; Masuda S; Nishibata Y; Nakazawa D; Tomaru U; Ishizu A
Mod Rheumatol; 2020 May; 30(3):544-550. PubMed ID: 30932727
[No Abstract] [Full Text] [Related]
20. B cell-mediated pathogenesis of ANCA-mediated vasculitis.
Jennette JC; Falk RJ
Semin Immunopathol; 2014 May; 36(3):327-38. PubMed ID: 24777746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
